Dr. Rangaraju is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 6th Ave S
Fl 5
Birmingham, AL 35233Phone+1 205-801-9304
Education & Training
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2020
- University of MinnesotaResidency, Internal Medicine, 2014 - 2017
- Manipal College of Medical ScienceClass of 2012
Certifications & Licensure
- AL State Medical License 2020 - 2024
- IN State Medical License 2017 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Idarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia.Kendall Diebold, Garrett Bourne, Manuel Espinoza-Gutarra, Zaid Al-Kadhimi, Kimo Bachiashvili
Leukemia & Lymphoma. 2024-11-01 - 1 citationsAcute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Bijal Shah, Ryan J Mattison, Ramzi Abboud, Peter Abdelmessieh, Ibrahim Aldoss
Journal of the National Comprehensive Cancer Network. 2024-10-01 - 2 citationsAddition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemia.Garrett Bourne, Kendall Diebold, Manuel Espinoza-Gutarra, Zaid Al-Kadhimi, Kimo Bachiashvili
Leukemia Research. 2024-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: